Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.

By Trish Perl, J. Cullen, R. Wenzel, M. Zimmerman, M. Pfaller, D. Sheppard, Jennifer Twombley, Pamela French, L. Herwaldt. New England Journal of Medicine, 2002

719 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/38b0af34f2d0218d1eb0440a6ea24762ba31aafb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Critical Care and Intensive Care Medicine

1. Emily R. M. Sydnor
2. Trish Perl
3. Victoria J. Fraser

In Infectious Diseases

1. Emily R. M. Sydnor
2. Trish Perl

Citations in the corpus

• 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings (2007, neutral): “[46] [47] [48] [49] [50] [51] [52] [53] [54] I.B.2.”
• Hospital Epidemiology and Infection Control in Acute-Care Settings (2011, background): “aureus decreases rates of surgical-site infections (26, 249).”
• Clinical practice guidelines for antimicrobial prophylaxis in surgery. (2013, neutral): “aureus nasal colonization [146,160].”
• Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update (2014, background): “aureus SSI rate.(143) (a) In a secondary analysis of these data, the use of intranasal mupirocin was associated with an overall decreased rate of nosocomial S.”
• Strategies to Prevent Surgical Site Infections in Acute Care Hospitals (2008, background): “aureus carriers.(58) Mupirocin resistance has been documented.”